Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

JReport Powers TCS Healthcare Technologies with Advanced Embedded Analytics


ROCKVILLE, Md., Oct. 18, 2018 /PRNewswire-PRWeb/ -- JReport, the leading embedded analytics and reporting software solution, was selected as a partner by TCS Healthcare Technologies (TCS), a leading provider of managed care software and clinical content solutions. JReport will be embedded into TCS's new ACUITYnxt software to enable advanced reporting and analytics services for managed care organizations to improve overall managed care operations.

JReport's interactive, highly precise, self-service reporting and dashboard capabilities will provide the next level of advanced analytics for ACUITYnxt users. Specifically, ACUITYnxt clients will be empowered to interact with or even build their own aggregate reports, dashboards and letters, with ease. This will allow case managers and managed care nurses to improve the analysis of care management data and correspondence with each individual in their case load.

"We're very excited to deliver critical reporting and analytics tools backed by a world class development and support team to assist healthcare professionals to streamline their workflows in serving patients," said Dr. Bing Yao, CEO of Jinfonet Software. "We look forward to our continued partnership with TCS Healthcare in their mission to promote the best medical management practices and provide the most cost-effective technology solutions to support those processes."

"JReport brings a highly customizable, sophisticated reporting feature set to our intuitive and adaptable care management software solution, ACUITYnxt," said Rob Pock, CEO of TCS Healthcare Technologies. "With JReport, our clients will undoubtedly be better equipped to improve their business processes all from the convenience of ACUITYnxt, which they will be using for day-to-day care management operations."

JReport 15.5 is now available for download. To request a customized demo, please contact info(at)jinfonet.com or call (240) 477-1000.

ACUITYnxt is available in November 2018. To request a demo, please contact info(at)tcshealthcare.com or call (530) 886-1700 x203.

About Jinfonet Software
JReport from Jinfonet Software empowers companies to embed the most precise, high performance reports and dashboards into web applications. The embedded analytics platform provides developers and users with a scalable, fault tolerant solution that's easy to customize and work seamlessly as part of their applications on any platform, with any data source. Every day, JReport delivers insights for hundreds of thousands of users at over 10,000 OEM and enterprise installations worldwide.

More information on Jinfonet Software and JReport is available at https://www.jinfonet.com.

About TCS Healthcare Technologies
TCS Healthcare Technologies (TCS), based out of Sacramento, CA, is a leading provider of software and clinical solutions that support and improve medical management operations for health plans, specialty plans, TPAs and risk-bearing provider groups. TCS's team of US-based clinicians and developers are recognized for their best-in-class managed care expertise and customer support throughout the industry.

To learn more about ACUITYnxt and TCS Healthcare Technologies, visit https://www.tcshealthcare.com.

 

SOURCE Jinfonet Software


These press releases may also interest you

at 13:00
Building on its 2014 rollout of the Free Subscription Program of the company's cloud-based My eMHR Personal Health Records system for disabled veterans, ISeeYouCare has created a separate platform solely for use by Disabled Veterans called 'VLPHR for...

at 11:25
Strengthening its leadership in delivering innovative new solutions to transform cancer care globally, Varian today announced Ethostm therapy, an Adaptive Intelligencetm solution. Ethos therapy is an artificial intelligence (AI)-driven holistic...

at 11:00
Nocira, LLC announces its fourth and fifth US Patents, US 10,251,790 and 10,278,868, issued by the U.S. Patent and Trademark Office related to its novel approach for treating headaches via ear pressure modulation. Nocira...

at 10:00
TAE Life Sciences, a company pioneering a new cancer treatment platform that addresses limitations in current cancer therapy, today announced the formation of a Scientific Advisory Board to facilitate groundbreaking advancements in the emerging field...

at 09:00
Oncopeptides AB  announced today updated interim efficacy and safety data from the ongoing pivotal Phase 2 study, HORIZON, at the 17th International Myeloma Workshop (IMW) meeting in Boston, Massachusetts, USA. The data focused on patients with...

at 08:00
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized Phase 2 GRIFFIN (MMY2004) study showing that the addition of DARZALEX® (daratumumab) to bortezomib, lenalidomide and dexamethasone (VRd) induced...



News published on 18 october 2018 at 08:00 and distributed by: